About Dr. Srinivas Chilukuri
Dr. Srinivas Chilukuri is a highly accomplished and respected radiation oncologist with over 22 years of experience, widely recognised as a key opinion leader in high-precision radiation therapy, including cutting-edge Particle Beam Therapy. He is credited with pioneering South Asia and India’s first clinical programme for particle beam therapy for paediatric, prostate, thoracic cancers and sarcomas, establishing him as a top radiation oncologist in India. Dr. Chilukuri has numerous high-impact international scientific publications and several national and international awards, including the ASCO IDEA award. His expertise extends to advanced techniques like Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiotherapy (SBRT), making him a leading radiation oncologist in Chennai and a champion for equitable, technologically advanced cancer care across India.
Qualifications & Credentials
- MBBS
- MD Radiation Oncology
- Fellowship awarded by the American Society of Oncology (ASCO) for promising oncologists.
- Fellowship awarded by the European Society of Medical Oncology (ESMO) for promising oncologists.
- Radiosurgery Fellowship at VU University Medical Centre, Amsterdam.
Areas of Expertise
- Paediatric Cancers
- Urological Cancers
- Thoracic Cancers
- Bone and Soft Tissue Tumours
- Lymphomas
- Head and Neck Cancers
- High Precision Radiation Therapy
- Particle Beam Therapy (Proton Beam Therapy)
- Stereotactic Radiosurgery (SRS)
- Stereotactic Body Radiotherapy (SBRT)
- Adaptive Radiotherapy
- Pencil Beam Scanning Proton Beam Therapy
- Multi-isocentric 4π volumetric modulated arc therapy (VMAT)
- Image-Guided Radiation Therapy (IGRT)
- RapidArc
- Stereotactic Radiosurgery (intracranial and extracranial sites)
- Stereotactic Radiotherapy
- Adaptive Radiotherapy
Professional Experience
- Senior Consultant - Radiation Oncology at Apollo Proton Cancer Centre, Chennai
- Consultant - Medical Affairs for Varian Medical Systems
- Chairman of Optimus Oncology Pvt. Ltd.
- Senior Radiation Oncologist at Yashoda Superspeciality Hospital
- Senior Resident at Tata Memorial Centre
- Lead Faculty at Varian Advanced Radiotherapy School
- Visiting Professor at Vanderbilt University Medical Centre
- Clinical Director for Advanced Radiotherapy School, which has trained numerous oncologists and medical physicists.
- In-charge of academics and tumour boards at YCI, supervising 14 DNB students.
- Regular invited faculty at various national and international meetings.
- Part of a select ICMR panel for national guidelines on gastric cancers.
- Initiated South Asia and India’s first clinical programme for particle beam therapy for paediatric, prostate, thoracic cancers, and sarcomas.
- Significantly contributed to establishing RapidArc, IGRT, SRS, and SBRT programmes at YCI.
- Instrumental in establishing and running High Precision Radiotherapy (in collaboration with Varian Medical Systems), training over 220 radiation oncologists and physicists.
- Co-founded Optimus Oncology to provide modern and affordable cancer care in rural India.
- Won several national and international awards.
- Successfully organised a national-level meeting of the Indian Society of Neuro-Oncology at Hyderabad.
Awards & Recognitions
- American Society of Clinical Oncology (ASCO) IDEA award (2013) for being among the most promising young oncologists.
- CHIKITSA RATTAN award and gold medal for excellence in medical science by the INTERNATIONAL STUDY CIRCLE, NEW DELHI (2007).
- BHARAT JYOTHI award, for contribution to education in the field of minimal access surgery by the IIFS, New Delhi (2010).
- “MOTHER TERESA AWARD” for advances in medicine, by the Integrated Council for Socio Economic Development, Bangalore (2012).
- “Teaching Excellence Award” by the Indus Global Foundation during the Indo Global Educational Summit, Hyderabad (November 2015).
- Conferred the title of “Distinguished Clinical Tutor” by the Apollo Hospital Educational Research Foundation (AHERF) (2017).
- Fellowships from American Society of Oncology and European Society of Medical Oncology.
- More than 30 recent publications in high-impact international journals.
- Member of American Society of Oncology (ASCO), American Society of Radiation Oncology (ASTRO), European Society of Radiation and Oncology (ESTRO), European Society of Medical Oncology (ESMO), Pediatric Radiation Oncology Society, Society of Neuro-oncology, Association of Radiation Oncologists of India (AROI), Indian Society of Neuro-oncology (ISNO).
Research & Publications
- Subramaniam S, Srinivas C, et al. "Multi-isocentric 4 pi volumetric modulated arc therapy approach for head neck cancer." J Clin App Med Phys (2017, Sep 18(5):293-300).
- Subramaniam SV, Subramani V, Thirumalai S, Gandhi A, Srinivas C. "Is 5mm MMLC suitable for VMAT-based SBRT? A dosimetric comparison with 2.5mm HDMLC using RTOG 0813 treatment planning criteria for conventional and high dose flattening filter photon beams."
- Shrikhande SV, Sirohi B, Barreto SG, Chacko RT, Parikh PM, Pautu J, Arya S, Patil P, Chilukuri SC, Ganesh B, Kaur T, Shukla D, Rath GS. "Indian council of medical research consensus document on management of gastric cancers." Indian J Med Paediatr Oncol. (2014 Oct;35(4):239-43).
- Shrikhande SV, Sirohi B, Barreto SG, Chacko RT, Parikh PM, Pautu J, Arya S, Patil P, Chilukuri SC, Ganesh B, Kaur T, Shukla D, Rath GS. "Indian council of medical research consensus document on management of gastro-intestinal stromal tumors." Indian J Med Paediatr Oncol. (2014 Oct;35(4):244-248).
- Subramaniam S, Srinivas C, et al. "Volumetric Modulated Arc based hypofractionated stereotactic radiotherapy for the treatment of selective intracranial arterio-venous malformations." Int Journal Of Radiat Oncol Biol Phys (2012, March, 82(3), 1278-1284).
- Subramaniam S, Thirumalaiswamy S, Srinivas C et al. "Chest wall radiotherapy with volumetric modulated arcs and the potential role of flattening filter free photon beams." Strahlentherapie and Onkologie (2012, Jun;188(6):484-90).
- Laskar SG, G Baijal, V Murthy, S Chilukuri, et al. "Hypofractionated radiotherapy for T1N0M0 glottic cancer: Retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution." Clinical Oncology (2012;24(10):180-6).
- Jalali R, Dutta D, Srinivas C, Sarin R. "Micro multileaf collimator based stereotactic radiosurgery for the treatment of selected arterio-venous malformations: Techniques and Preliminary Experience." Journal of Cancer Research and Therapeutics (2009, Sep; (5):3:186-191).
- Laskar SG, Agarwal JP, C Srinivas, Dinshaw KA. "Radiotherapeutic Management of Locally Advanced Head and Neck Cancer." Expert Review of Anti-cancer Therapy. (2006, March (6):3;405-417).
- Chilukuri S, Laskar SG, Murthy V, Agarwal JP, Budrukkar A, Dinshaw KA. "Need for objective patient selection criteria for palliative radiotherapy in advanced head and neck cancer." Radiother Oncol (2008, May;82(2) 308).
- Srinivas C, JP Agarwal, S Ghosh Laskar, T Gupta, KA Dinshaw. "Altered Fractionated Radiotherapy in Head and Neck cancer: In response to the MARCH meta-analysis by Bourhis et al." Lancet (2006:368; 1867).
- Jalali R, Srinivas C, TD Nadkarni, P Rajasekharan. "Suprasellar Hemangiopericytoma- Challenges in diagnosis and treatment." Acta Neurochirurgica (European Journal of Neurosurgery) (2008, Jan;150(1):67-71).
- Srinivas C, T Gupta, Preetha R. "Bilateral Mandibular metastasis in Medulloblastoma An unusual occurrence." Journal of Clinical Neuroscience (2009, Feb; 16(2):325-8).
- Chopra S, Engineer R, Mahantshetty U, Misra S, Phurailatpam R, Paul SN, Kannan S, Kerkar R, Chilukuri S, et al. "Phase III randomized trial of image guided intensity modulated radiotherapy (IG-IMRT) and conventional radiotherapy for late small bowel toxicity reduction after postoperative adjuvant radiation in Ca cervix:Study Protocol." British Medical Journal. (In Press 2010).
Patient Success Stories & Testimonials
- Pioneered India's first particle beam therapy programme for paediatric, prostate, thoracic cancers, and sarcomas, significantly expanding treatment options for these challenging conditions.
- Successfully treated numerous patients using highly precise radiation techniques, achieving excellent local control rates and minimising side effects.
- Guided 14 DNB students in radiation oncology, contributing to the next generation of specialists.
Treatment Approach & Philosophy
Treatment Costs
Treatment Type | Estimated Cost (INR) | Estimated Cost (USD) |
Proton Beam Therapy (Paediatric) | 25,00,000 - 45,00,000 | 30,000 - 54,000 |
Proton Beam Therapy (Adult Cancers) | 20,00,000 - 40,00,000 | 24,000 - 48,000 |
Stereotactic Radiosurgery (SRS) | 3,00,000 - 8,00,000 | 3,600 - 9,600 |
Stereotactic Body Radiotherapy (SBRT) | 3,50,000 - 9,00,000 | 4,200 - 10,800 |
Image-Guided Radiation Therapy (IGRT) | 2,00,000 - 6,00,000 | 2,400 - 7,200 |
Intensity-Modulated Radiation Therapy (IMRT) | 1,80,000 - 5,50,000 | 2,160 - 6,600 |
General Radiation Therapy (Conventional) | 1,00,000 - 3,00,000 | 1,200 - 3,600 |